Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1046-1047 (17 May), doi:10.1136/bmj.326.7398.1046
The lack of a national service framework should not allow us to ignore it
| The first 150 words of the full text of this article appear below. |
Chronic obstructive pulmonary disease causes significantly more mortality and morbidity than other causes of airflow limitation in adults1 but is underdiagnosed and under-recognised. The World Health Organization estimates that chronic obstructive pulmonary disease is the fourth leading cause of death worldwide, with 2.74 million deaths in 2000, and this burden is growing rapidly.2 The main cause is cigarette smoking, and the United Kingdom is now experiencing the ravages of a past high prevalence of smoking in its ageing population. Costs for 1996-7 showed that the NHS spent more than £818m ($1.3bn; €1.2bn) on the disease.3
In the United Kingdom chronic obstructive pulmonary disease accounts for as
many as one in eight medical
admissions.1
Emergency admissions for chronic obstructive pulmonary disease have recently
risen dramatically, contributing notably to the hospital bed
crisis.4 Annual
admissions peak in early January, due, in part, to increased respiratory
illness, acute exacerbations, and reduced primary care
David Price, general practice airways group professor of primary care respiratory medicine
Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Aberdeen AB25 2AY (d.price@abdn.ac.uk)
Martin Duerden, senior lecturer in therapeutics
Department of Medicines Management, Keele University, Keele, Staffordshire ST5 5BG (m.duerden@keele.ac.uk)
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+